Identification of DDIT4 as a potential prognostic marker associated with chemotherapeutic and immunotherapeutic response in triple-negative breast cancer

Identification of DDIT4 as a potential prognostic marker associated with chemotherapeutic and immunotherapeutic response in triple-negative breast cancer

Abstract Background Triple-negative breast cancer (TNBC) is the most heterogenous and aggressive subtype of breast cancer. Chemotherapy remains the standard treatment option for patients with TNBC owing to the unavailability of acceptable targets and biomarkers in clinical practice. Novel biomarkers...

Full description

Bibliographic Details
Main Authors: Xuanzhao Chen, Zeyan Li, Meihua Liang, Ziyang Zhang, Di Zhu, Biyun Lin, Renyu Zhou, Yuanzhi Lu
Format: Article
Language:English
Published: BMC 2023-06-01
Series:World Journal of Surgical Oncology
Subjects:
TNBC
Bioinformatics
Prognosis
Targeting therapy
Immune microenvironment
Online Access:https://doi.org/10.1186/s12957-023-03078-7

Internet

https://doi.org/10.1186/s12957-023-03078-7

Similar Items